2 No-Brainer Dividend Stocks to Buy With $100 in November

Core Viewpoint - The stock market offers excellent dividend-paying stocks that are accessible even to investors with modest budgets, particularly through commission-free trading and fractional shares. Group 1: Coca-Cola - Coca-Cola has increased its dividend for 63 consecutive years, making it a strong consideration for income investors [3] - The company maintains high demand for its products regardless of economic conditions, allowing for continued dividend increases even during downturns [4] - Coca-Cola has successfully launched new products, such as Coca-Cola Spiced and Simply Pop, to keep consumer interest alive [5] - The company has a market cap of $303 billion, with shares trading at approximately $70.61 and a dividend yield of 0.03% [7] - Coca-Cola's pricing power helps it mitigate risks from tariffs and maintain sales, showcasing its strong business model [8] - The company is expected to continue its long track record of dividend increases, making it a solid buy-and-hold option [9] Group 2: Pfizer - Pfizer's revenue declined by 6% year-over-year to $16.7 billion in the third quarter, with adjusted earnings per share falling 18% to $0.87 [10] - The company has implemented cost-cutting initiatives projected to save $7.2 billion by the end of 2027, which may improve its bottom line [11] - Pfizer's stock is currently priced around $24.45, with a forward P/E ratio of 8.7, significantly lower than the healthcare industry average of 17.1, indicating it may be undervalued [13] - The company offers a forward dividend yield of approximately 7%, which is well above the S&P 500's average of 1.2%, appealing to patient investors [13]